Metformin and Gefitinib Cooperate to Inhibit Bladder Cancer Growth via Both AMPK and EGFR Pathways Joining at Akt and Erk

Scientific Reports - United Kingdom
doi 10.1038/srep28611
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Dihydroartemisinin and Gefitinib Synergistically Inhibit NSCLC Cell Growth and Promote Apoptosis via the Akt/mTOR/Stat3 Pathway

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2017English

Linc01014 Regulates Gefitinib Resistance in Oesophagus Cancer via EGFR‐PI3K‐AKT‐mTOR Signalling Pathway

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2019English

GDF15 Derived From Both Tumor-Associated Macrophages and Esophageal Squamous Cell Carcinomas Contributes to Tumor Progression via Akt and Erk Pathways

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2015English

Simvastatin Inhibits Renal Cancer Cell Growth and Metastasis via AKT/mTOR, ERK and JAK2/STAT3 Pathway

PLoS ONE
Multidisciplinary
2013English

Modulation of Gene Expression and Cell-Cycle Signaling Pathways by the EGFR Inhibitor Gefitinib (Iressa) in Rat Urinary Bladder Cancer

Cancer Prevention Research
MedicineCancer ResearchOncology
2011English

Curcumin Attenuates Hyperglycemia-Driven EGF-induced Invasive and Migratory Abilities of Pancreatic Cancer via Suppression of the ERK and AKT Pathways

Oncology Reports
MedicineCancer ResearchOncology
2018English

Targeting TF-AKT/ERK-EGFR Pathway Suppresses the Growth of Hepatocellular Carcinoma

Frontiers in Oncology
Cancer ResearchOncology
2019English

Inactivation of Both FHIT and P53 Cooperate in Deregulating Proliferation-Related Pathways in Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2012English

Metformin Inhibit Cervical Cancer Migration by Suppressing the FAK/Akt Signaling Pathway

Asian Pacific Journal of Cancer Prevention
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy